Moderna sobe à medida que as vendas de vacinas COVID no exterior impulsionam a batida do terceiro trimestre, aumento de

Moderna (MRNA) stock rises as the company posts better-than-expected Q3 2026 results and lifts its full-year growth outlook. Read more here.

CryptoAlerta — análise de criptomoedas e mercado em tempo real